UVEITIS TREATMENT MARKET ANALYSIS

Uveitis Treatment Market, by Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), by Disease type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2020
Code : CMI1094
Pages :186
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Uveitis Treatment Market: Key Developments

Increasing research initiatives for launch of phase 3 clinical trials by market players is expected to drive the global uveitis treatment market growth over the forecast period. For instance, on August 16, 2022 Tarsier Pharma, a pharmaceutical company, focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular back and front of the eye blinding diseases, announces development Of TRS02, A Potential Immunomodulator, for the treatment of retinal diseases such as posterior uveitis (intermediate, posterior, and pan uveitis), diabetic macular edema, non-proliferative diabetic retinopathy, and dry-age-related macular degeneration.